OncoSil Medical Limited is located in Sydney, Australia on 15 Castlereagh St. OncoSil Medical Limited is rated 3 out of 5 in the category biotechnology in Australia. OncoSil Medical is a Sydney-based medical device company focused on Interventional Oncology in the pancreas and liver. OncoSil Medical has developed a medical device called the OncoSil™ System, and is progressing towards its commercialisation. The device is currently undergoing clinical studies in leading academic sites globally. The clinical data will be used for regulatory submission within targeted markets including Europe, United States, Australia and Asia. OncoSil™ is a brachytherapy device that implants a pre-determined dose of beta radiation via injection under Endoscopic Ultrasound (EUS) guidance. The beta particles emitted by OncoSil™ travel a short distance in tissue causing damage to targeted cell DNA, which renders them incapable of further cell division and proliferation. OncoSil Medical is currently undertaking clinical studies to investigate the clinical benefit of the addition of OncoSil™ when combined with standard of care chemotherapies in the pancreas. Details on this site may include information regarding OncoSil™, which may not currently have approval in your region.
Address
15 Castlereagh St
Company size
11-50 employees
Accessibility
Wheelchair-accessible entrance